Aims/hypothesis Adipocyte lipopolysaccharide-binding protein (LBP) biosynthesis is associated with obesity-induced adipose tissue dysfunction. Our purpose was to study the role of LBP in regulating the browning of adipose tissue. Methods Adult mice were maintained at 4°C for 3 weeks or treated with the β 3 -adrenergic agonist, CL316,243, for 1 week to induce the browning of white fat. Precursor cells from brown and white adipose tissues were cultured under differentiation-inducing conditions to yield brown and beige/ brite adipocytes, respectively. In vitro, Lbp was knocked down in 3T3-L1 adipocytes, and cells were treated with recombinant LBP or co-cultured in transwells with control 3T3-L1 adipocytes. Wild-type and Lbp-null mice, fed a standard or high fat diet (HFD) for 15 weeks, were also used in investigations. In humans, subcutaneous and visceral adipose tissue samples were obtained from a cohort of morbidly obese participants.
Introduction
Obesity is characterised by lipid accumulation in white adipose tissue (WAT) as a consequence of a disturbed energy balance due to increased food energy intake and/or lowered energy expenditure. Importantly, it is associated with an increased incidence of metabolic disorders, especially type 2 diabetes mellitus [1] . Brown adipose tissue (BAT) is characterised by the presence of multivacuolar adipocytes with a thermogenic capacity that reflects the natural uncoupling of their mitochondria, as mediated by uncoupling protein 1 (UCP1). BAT is the main site of adaptive energy expenditure in response to cold and possibly to diet [2] . In experimental models, enhanced BAT activity is associated with protection against obesity, whereas impaired BAT activity favours an obese phenotype. Moreover, BAT is a major site of lipid breakdown and glucose uptake; therefore, BAT activation is associated with improvements in hyperlipidaemia and hyperglycaemia [3, 4] . In humans, it was previously thought that BAT is only present in neonates. However, more recent research has established that adult humans retain substantial BAT activity [5, 6] . In addition to the presence of BAT at defined anatomical locations, recent studies have attached special relevance to the WAT browning process [7] . This phenomenon consists of the appearance of functionally thermogenic brown adipocyte-like cells (so-called beige or brite adipocytes) in WAT depots. Several studies in mice have indicated that the capacity to activate this process may protect against diet-induced obesity and systemic metabolic disturbances [8, 9] , although the actual relevance of adipose tissue browning to metabolism is still a matter of debate [10, 11] .
Lipopolysaccharide (LPS)-binding protein (LBP) is a type I acute-phase reactant protein, thought to be mainly produced by the liver [12] . LBP facilitates the binding of the lipid A component of LPS to CD14 and toll-like receptor 4 (TLR4) [13] , thus modulating the immunostimulatory capacity of LPS in bacterial infections [14] . LBP is also present in adipose tissues and high levels of LBP synthesis in white adipocytes are associated with WAT dysfunction in obesity [15] . LBP expression is associated with inflammatory markers and is increased with metabolic deterioration and insulin resistance in obese patients [16] . Here, we sought to establish the role of LBP in the browning of WAT. We investigated the association of Lbp expression with browning and studied alterations in browning and metabolism in Lbp-null mice.
Methods
Exposure of mice to chronic cold and treatment with CL316,243 The care and use of mice was carried out in accordance with the European Community Council Directive 86/609/EEC and approved by the Institutional Animal Care Committee of the University of Barcelona. C57BL/6 mice (Harlan Laboratories; Indianapolis, IN, USA) were maintained under standard conditions (12 h light/12 h dark cycle, 21 ± 1°C). Where indicated, 3-month-old mice were exposed to 4°C for 3 weeks, or 2-month-old mice received daily i.p injections with 1 mg/kg CL316,243 for 8 days (see electronic supplementary material [ESM] Methods; exposure of mice to chronic cold, and treatment of mice with CL316,243, for further details).
Adipocyte culture For primary adipocyte cultures, the stromal-vascular fraction was isolated from the inguinal WAT (iWAT) and interscapular BAT (iBAT) depots of 1-month-old mice. Pre-adipocytes were induced to differentiate into beige/brite and brown adipocytes, respectively, as previously reported [17, 18] . Differentiated beige/brite and brown adipocytes were treated with 0.5 μmol/l noradrenaline (norepinephrine) for 6 h. Differentiation of 3T3-L1 fibroblasts (ATCC; LGC Standards, Barcelona, Spain) was induced by treatment with 0.86 μmol/l insulin, 0.5 μmol/l dexamethasone and 0.5 mmol/l 3-isobutyl-1-methylxanthine (IBMX) for 2 days, followed by 0.86 μmol/l insulin alone for 5 days. See ESM Methods for further details.
LBP knockdown and co-culture experiments Stable silencing of Lbp was achieved by transfecting 3T3-L1 fibroblasts with small hairpin (interfering) RNA (shRNA) targeting mouse Lbp (shLBP)or control shRNA (shControl) (Sigma Mission shRNA; Sigma-Aldrich, St Louis, MO, USA) as previously reported [16] , generating transfected cells described in this paper as shRNA-mediated LBP knockdown (shLBP) or control (shControl) cells, respectively. Where indicated, shLBP adipocytes were incubated with 10 ng/ml LBP (R&D Systems; Minneapolis, MN, USA) during differentiation. Differentiated shLBP or shControl 3T3-L1 adipocytes were placed on one side of a Transwell plate (VWR-International Eurolab, Barcelona, Spain) and co-cultured with shLBP adipocytes on the other side. See ESM Methods for further details.
Lbp-null mouse studies Lbp-knockout mice (C.129P2-Lbptm1Jack/J, Balb strain background; obtained from The Jackson Laboratory, Bar Harbor, ME, USA) were maintained at 21 ± 1°C. Five-week-old male Lbp-null and wild-type (WT) littermate mice were fed standard chow (CTRL) or a high fat diet (HFD) for 15 weeks. For GTTs, 2.5 g glucose/kg was administered i.p. to mice starved for 6 h. For Human study Paired subcutaneous and visceral adipose tissue (VAT) samples (n = 38) from a cohort of morbidly obese (BMI >35 kg/m 2 ) participants were studied. These participants were recruited, gave written informed consent, and were validated and approved by the ethical committee at the Hospital of Girona 'Dr Josep Trueta'. Samples were obtained from subcutaneous adipose tissue (SAT) and VAT depots during elective surgical procedures. See ESM Methods for further details.
RNA isolation, cDNA synthesis and real-time PCR Total RNA was isolated (Macherey-Nagel, Düren, Germany) from BAT, iWAT, eWAT and liver samples from mice, and SAT and VAT samples from humans and retrotranscribed using Ta q M a n R e v e r s e Tr a n s c r i p t i o n R e a g e n t s ( L i f e Technologies). For the quantitative analysis of mRNA, TaqMan quantitative real-time PCR was performed on a 7500 Real-Time PCR System (Life Technologies) using the specific primer pair/probe sets, as described in ESM Table 1 . See ESM Methods for further details.
Western blot assays Western blot analysis was performed on BAT and iWAT samples following standard procedures, using primary anti-UCP1 (1:1000; Abcam, Cambridge, UK) and anti-β-actin (1:5000; Sigma-Aldrich) antibodies. Both antibodies were diluted in 1× PBS containing 0.1% Tween-20, as per manufacturer's instructions. See ESM Methods for further details.
Statistical methods Results are expressed as mean ± SEM. Statistical analyses were performed using GraphPad Prism 6 (La Jolla, CA, USA). The statistical significance of differences was assessed using unpaired Student's t tests, one-way ANOVA with Tukey's multiple comparison test, or two-way ANOVA with Bonferroni post-testing, as appropriate.
Results
Induction of browning in subcutaneous WAT is associated with reduced Lbp expression We subjected mice to longterm cold exposure (4°C for 3 weeks) and then examined Lbp gene expression in adipose tissue depots. As expected, cold exposure increased expression of the thermogenesisrelated genes Ucp1, Sirt3, Fgf21 and Ppargc1a in subcutaneous WAT (i.e. iWAT; Fig. 1d-h) ; it also induced the browning process, indicated by the appearance of large amounts of multilocular adipocytes (Fig. 1a,b ). These changes were associated with a marked reduction in Lbp expression (Fig. 1c) . Lbp expression in visceral WAT (i.e. epididymal WAT [eWAT]), a WAT site less prone to browning, was also decreased in mice exposed to chronic cold, albeit to lesser extent (ESM Fig. 1a ). In contrast, chronic cold exposure did not modify Lbp expression in iBAT (ESM Fig. 1h ), even though we observed significant induction of thermogenesisrelated genes in this tissue (ESM Fig. 1i-n) .
Chronic treatment of mice with the β 3 -adrenergic agonist CL316,243 (a model of induction of browning in iWAT and eWAT [20] ), triggered the appearance of multilocular adipocytes (Fig. 1l, m) , induced thermogenesis-related gene expression ( Fig. 1o-v ) and strongly repressed Lbp gene expression ( Fig. 1n ) in iWAT and eWAT (ESM Fig. 2a-i ). Although iBAT also showed signs of activation following CL316,243 treatment (e.g. the induction of Dio2 and Bmp8b), Lbp expression was not significantly altered in this tissue (ESM Fig. 2l-r) . Overall, our results suggest that the downregulation of LBP is more strongly associated with WAT browning than with the induction of thermogenesis in iBAT.
Lbp expression is involved in the repression of browning in adipocytes In order to determine whether the inverse relationship between Lbp expression and browning is a cellautonomous phenomenon, we used rosiglitazone-induced browning (i.e. acquisition of the beige/brite phenotype) in precursor cells obtained from iWAT [17, 21] . Incubation of iWAT precursor cells with rosiglitazone during differentiation induced the expression of several marker genes for browning ( Fig. 2b-f) , and repressed Lbp expression (Fig. 2a) , without affecting the expression of the general adipogenesis-related genes Slc2a4 (also known as Glut4), Adiponectin (Adipoq) and Pparg ( Fig. 2g-i ). These data confirm that negative regulation of LBP expression is associated with the adipocyte browning. Moreover, treatment of differentiated beige/brite adipocytes with noradrenaline repressed Lbp and induced Ucp1 gene expression (ESM Fig. 3a,b) ; however, noradrenaline did not modify Lbp expression in brown adipocytes (ESM Fig. 3c ).
To investigate whether LBP has a direct role in the browning process, we studied the effects of shRNAmediated LBP knockdown in 3T3-L1 adipocytes. After 7 days of differentiation, shLBP exhibited increased mRNA levels of several thermogenesis-related genes, including Ucp1, Ppargc1a and Sirt3 (Fig. 2k-o) . Treatment of shLBP cells with recombinant LBP rescued the induction of Ucp1 mRNA expression induced by loss of Lbp (Fig. 2s) . Moreover, shLBP adipocytes subjected to transwell co-culture with control adipocytes showed lower levels of Ucp1 mRNA expression compared with those co-cultured with shLBP cells (Fig. 2t) . Overall, these data suggest that the downregulation of Lbp represses browning in a cell-autonomous manner.
Lbp-null mice exhibit reduced body weight gain accompanied by an induction of the browning process in iWAT To study the role of LBP in vivo, Lbp-null mice and WT littermate controls were fed standard chow (CTRL) or an 25 5,000 4,000 3,000 2,000 8 (n-v) Transcript levels of (n) Lbp,
u) Pparg and (v) Adipoq from control mice (white bars) or mice injected with CL316,243 (black bars). mRNA levels are normalised to 18S rRNA levels. Data are presented as mean ± SEM of six independent samples per group. *p < 0.05, **p < 0.01, and ***p < 0.001 HFD for 15 weeks. At the start of the experiment (5-week-old mice), body weight was similar between WT and Lbp-null mice. The body weight of WT mice increased to 144% of the initial weight under standard feeding conditions and to 162% when fed an HFD (Fig. 3a,b) . When fed a standard (CTRL) diet, the increase in body weight was significantly lower in Lbp-null mice (135%) than in WT mice on the same diet. On an HFD, the body weight of Lbp-null mice increased to only 145% of their initial weight; this increase was not significantly different from the body weight increase in Lbp-null mice on a standard diet. Lbp-null mice did not show significant changes in food intake relative to WT mice under standard diet (105 ± 4% kJ/day in Lbp-null vs WT) or HFD (112 ± 8% kJ/day in Lbp-null vs WT) conditions. Oxygen consumption was not significantly different among the different experimental groups (Fig. 3c) .
The RQ was significantly decreased in WT mice fed HFD (Fig. 3d) . In Lbp-null mice, RQ did not change significantly in response to an HFD, indicating a somewhat altered metabolic flexibility to adapt to HFD as a consequence of Lbp invalidation.
Lbp-null mice showed no statistically significant alterations in blood glucose levels (Fig. 3e) , whereas Lbp-null mice had higher plasma triacyclglycerol levels when maintained on an HFD diet (Fig. 3f) . Insulinaemia was strongly increased in Lbp-null mice relative to WT mice on an HFD (Fig. 3g ). There were no differences in plasma NEFA, 3-hydroxybutyrate, leptin, adiponectin or resistin levels between WT and Lbp-null Table 2 ). Of the proinflammatory factors, HFD strongly induced circulating IL-6 levels in WT mice; this effect was totally ablated in Lbp-null mice (Fig. 3h) . Consistent with the Balb genetic background of these mice, HFD did not affect glucose tolerance or the insulin response of WT mice, as determined by GTTs and ITTs (Fig. 3i,j) [22] . However, Lbp-null mice exhibited marked glucose intolerance and reduced insulin sensitivity on both a standard diet and HFD.
Under both standard diet and HFD conditions, Lbp-null mice showed a marked induction of the browning phenotype markers Ucp1 and Dio2 in iWAT (Fig. 4a,b) . Other marker genes, including Prdm16, Fgf21 and Ppargc1a (Fig. 4c-e) , showed a similar trend that did not reach statistical significance between groups, although multifactorial ANOVA analysis revealed a significant increase in Fgf21 (p = 0.03) for the Lbp-null factor. iWAT depots showed clusters of multivacuolar adipocytes (with beige/brite morphology) in Lbp-null mice, consistent with the gene expression data (Fig. 4j-m) . Expression of genes involved in overall adipogenesis (Pparg, Leptin [Lep], and Adipoq) did not change (Fig. 4g-i) , whereas multifactorial ANOVA analysis revealed a significant increase in Slc2a4 (p = 0.04) for the Lbp-null factor. The amount of UCP1 protein per iWAT depot was higher in Lbp-null mice than in WT mice under both standard diet and HFD conditions (Fig 4p) . Under conditions that promoted the highest browning, the amount of UCP1 protein in iWAT was around 8% of the levels observed in iBAT. Explants of iWAT from Lbp-null mice had an increased rate of glucose oxidation (Fig. 4q) , but no change in the incorporation of glucose into lipids (Fig. 4r) . This result indicates that oxidative pathways are enhanced in iWAT from Lbp-null mice, which is consistent with the molecular and morphological signs of browning in iWAT.
No evidence of significant browning due to Lbp gene ablation was detected in eWAT under any feeding condition, whether determined by gene expression analysis (with the exception of Dio2; ESM Fig. 4 ) or microscopic examination (data not shown).
iBAT in Lbp-null mice iBAT weight tended to be higher in Lbp-null mice relative to controls (Fig. 5a ) and total iBAT protein content was significantly higher in Lbp-null mice (Fig. 5b) , indicating functional hypertrophy of iBAT in response to the lack of LBP. Consistent with this, the local temperature in the iBAT region was higher in Lbp-null mice than in WT mice, at least under standard diet conditions (Fig. 5c) .
Total UCP1 per iBAT depot was increased in Lbp-null mice (Fig. 5e,f) , although relative Ucp1 transcript levels were not significantly altered (Fig. 5d) . This scenario is consistent with a long-term BAT recruitment process [23] . Transcript levels for other thermogenesis-related genes showed no major changes due to LBP ablation, except for a significant induction of Dio2 in the HFD group (Fig. 5g-k) .
Hepatic alterations in Lbp-null mice Liver size and hepatic triacylglycerol content were unaltered in Lbp-null mice (data not shown). Expression of genes encoding gluconeogenesis-related enzymes (G6pase and Pepck) tended to be lower in Lbp-null mice (ESM Fig. 5a,b) . The hepatic expression of Srebp, a master regulator of lipid synthesis, as well as Fas, Scd1 and Acaca, was significantly reduced in Lbp-null mice under CTRL conditions (ESM Fig. 5c-f ). Il6 gene expression was undetectable under CTRL conditions in both WT and Lbp-null mice, but was strongly induced under HFD. This induction was impaired in Lbp-null mice, a profile that paralleled circulating IL-6 levels (ESM Fig. 5i ).
LBP expression negatively correlates with the expression of browning marker genes in human subcutaneous adipose tissue We analysed the expression of LBP and browning marker genes in SAT and VAT biopsies from morbidly obese patients. Anthropometrical and clinical v a r i a b l e s i n c l u d e d a g e ( 4 8 . 3 ± 9 . 1 y e a r s ) , B M I (43.8 ± 6.9 kg/m 2 ), percentage fat mass (56.1 ± 10.1%), fasting glucose (5.33 ± 0.67 mmol/l) and M value (23.5 ± 13.3 μmol kg −1 min −1 ). We found significant negative correlations between LBP transcript levels and the levels of transcripts for the browning marker genes UCP1, PRDM16, PPARGC1A and TMEM26 (the latter being a putative marker of beige/brite adipocytes [24] ) in SAT (Table 1) . No such correlation was found between LBP expression and general markers of WAT such as PLIN1, LEP or DGAT1. In VAT, LBP mRNA levels negatively correlated with TMEM26 mRNA levels and positively correlated with LEP mRNA levels ( Table 1) . Data are Spearman's r coefficients *p < 0.05, **p < 0.01 and ***p < 0.001
Discussion
In addition to its immunostimulatory functions [14] , LBP has been identified as an adipokine associated with obesityinduced metabolic and proinflammatory disorders [15, 16] . The promotion of BAT activity and, especially, of WAT browning are active research areas that hold promise for strategies aimed at protecting against obesity and associated metabolic abnormalities (e.g. hyperglycaemia and hyperlipidaemia) [24, 25] . Here, we report that both cold exposure and chronic treatment with a β 3 -adrenergic agonist (two validated models for inducing WAT browning [20, 26] ) were associated with dramatic decreases in Lbp gene expression in iWAT. This phenomenon occurred in a cell-autonomous manner: Lbp expression was strongly repressed in cultures of adipocytes induced to acquire a beige/brite phenotype. Moreover, silencing of Lbp expression in adipocytes enhanced the expression of browning marker genes, whereas LBP treatment reversed this effect. As LBP is secreted by adipocytes, these data suggest that LBP may negatively regulate browning, apparently in an autocrine manner.
We observed that Lbp-null mice were protected against body weight increases, which is consistent with the relationship observed between obesity and Lbp expression in the adipose tissues of human patients and mouse models [15] . In rodents, the thermogenic activity in BAT accounts for a significant proportion of whole body energy expenditure [27] ; therefore, the observed activation of BAT in Lbp-null mice may be involved in reducing weight gain. Moreover, although the estimated total thermogenic capacity of 'browned' WAT is much lower than that of BAT [23] , browning of WAT is proposed to be relevant to protection against HFD-induced obesity [8, 9] . Our results indicate that a lack of LBP in mice strongly enhances the browning of WAT, thus indicating that the in vitro function of LBP as negative regulator of browning also occurs in vivo. These findings support the concept that LBP, possibly acting in an autocrine manner, negatively regulates the browning process. The negative correlation between Lbp expression and marker genes of browning in human adipose samples is consistent with this scenario. The signs of BAT activation in mice lacking LBP appear to contrast with the minor association of BAT activation with Lbp downregulation in iBAT. It is possible that the effects of LBP deficiency on body weight in mice occur through alterations in Lbp expression in other tissues (e.g. nervous system) that indirectly contribute to regulation of BAT activity, and that the cell-autonomous effects of LBP deficiency are minor in the context of the whole animal. Furthermore, the lack of an overt increase in oxygen consumption (despite activated BAT and WAT browning) and unchanged food intake in Lbp-null mice could be due to changes in these variables that are too small to be measurable but have long-term consequences on body weight. In any case, these observations warrant further research to determine whether impaired absorption of food might be different in Lbp-null mice than in WT mice, given evidence for a role for LBP in gut biology [28] . In summary, the Lbp-null model supports a role for LBP in the browning process, but the pleiotropic phenotype in these mice (see below) precludes definitive conclusions on the impact of browning induction on whole-body energy balance.
The obesity resistance, promotion of browning and increased BAT activity observed in Lbp-null mice were accompanied by glucose intolerance and insulin insensitivity. Although seemingly unexpected, these findings can be viewed in relation to our current understanding that complex relationships exist between inflammatory pathways (Lbp-null mice also showed a decrease in systemic and local inflammatory markers, such as IL-6) and metabolic regulation. Numerous studies have demonstrated a positive association between serum LBP concentration and obesityassociated metabolic disturbances, including insulin resistance, in humans [29] [30] [31] [32] [33] . However, a discrepancy between circulating concentrations of innate immune system proteins in obese patients and the metabolic phenotype of the corresponding knockout mice has also been reported for lipocalin-2 [34, 35] and IL-6 [4, 36] . Other mouse models with loss of function of proinflammatory factors leading to impaired inflammation, such as the dominant-negative Tnfa transgenic mouse [37] and Fsp27-deficient mice [38] , show reduced inflammation in adipose tissue associated with weight loss, but also insulin resistance. In fact, mice lacking LPS-binding capacity due to Cd14 knockout show reduced proinflammatory responses to LPS, but with significantly impaired glucose tolerance [39] . Thus, although current concepts tend to support the hypothesis that adipose tissue expansion in obesity is associated with local inflammation, which contributes to insulin resistance, recent research indicates that a certain degree of inflammatory response is essential for healthy adipose tissue expansion [37] . Our findings suggest the possibility that total impairment of the LPS signalling pathway limits an appropriate inflammatory response, abolishing the improvement in glucose tolerance that might be expected as a consequence of protection against obesity.
In conclusion, LBP appears to be a negative regulator of WAT browning and possibly of BAT activation. This action of LBP may be relevant to its role in favouring obesity and fat accretion. However, a total lack of LBP, even if protective against obesity, does not result in a systemic healthy phenotype. The complexities of homeostatic vs deleterious roles of inflammatory pathways in metabolic regulation are highlighted in the mouse model of Lbp gene ablation. Fine-tuning LBP levels should be considered a part of any prospective use of this factor in promoting healthy metabolism. Duality of interest The authors declare that there is no duality of interest associated with this manuscript.
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